Deadly infections that can follow chemotherapy are the target of a landmark licensing deal between The University of Queensland and a United States-based biotech company.
19 November 2014Deadly infections that can follow chemotherapy are the target of a landmark licensing deal between The University of Queensland and a United States-based biotech company.
19 November 2014